CCND1 and mantle cell lymphoma: CyclinD1 immunostain is positive in 95% of cases; SOX11 expression, positive in 90–95% of MCL and negative in non-malignant lymphocytes and CLL/SLL, may be useful when CyclinD1 is negative [9,40,41].